Profile
Paula G.
O’Connor is Chief Medical Officer at Nurix Therapeutics, Inc. since 2024.
Formerly, Dr. O’Connor was Senior Vice President-Clinical Development at Protagonist Therapeutics, Inc. Education includes a doctorate from Stanford University School of Medicine and an undergraduate degree from Yale University.
Paula O’Connor active positions
| Companies | Position | Start |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2022 |
Former positions of Paula O’Connor
| Companies | Position | End |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2022 |
Education of Paula O’Connor
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Paula O’Connor
















